STOCK TITAN

Caredx Inc - CDNA STOCK NEWS

Welcome to our dedicated news page for Caredx (Ticker: CDNA), a resource for investors and traders seeking the latest updates and insights on Caredx.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Caredx's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Caredx's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.68%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.99%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.48%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.22%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.57%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.07%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.08%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.08%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.08%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.17%
Tags
none
Caredx Inc

Nasdaq:CDNA

CDNA Rankings

CDNA Stock Data

544.71M
50.66M
3.15%
100.39%
7.27%
Medical Laboratories
Health Care and Social Assistance
Link
US
South San Francisco

About CDNA

caredx: transforming transplant patient care through novel surveillance management solutions caredx, inc. is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. by combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, caredx is at the forefront of organ transplant surveillance and pre-transplant hla typing solutions. nasdaq:cdna about allosure® allosure is the first and only non-invasive blood test that directly measures allograft injury and identifies the probability of active rejection to better manage kidney transplant patients. allosure is a clinical-grade, proprietary next-generation sequencing (ngs) based test to detect donor-derived cell-free dna (dd-cfdna) in order to identify organ injury in kidney transplant recipients. allosure is analytically validated as a sensitive, specific, and precise measurement of dd-cfdna. allos